Current insights and assumptions on α-synuclein in Lewy body disease
DOI
10.1007/s00401-024-02781-3
Document Type
Journal Article
Publication Date
12-1-2024
Publication Title
Acta Neuropathologica
Volume
148
Issue
1
ISSN
16322
Keywords
Dementia, Lewy body, Neurodegeneration, Parkinson’s disease, Prion, Synuclein
Abstract
Lewy body disorders are heterogeneous neurological conditions defined by intracellular inclusions composed of misshapen α-synuclein protein aggregates. Although α-synuclein aggregates are only one component of inclusions and not strictly coupled to neurodegeneration, evidence suggests they seed the propagation of Lewy pathology within and across cells. Genetic mutations, genomic multiplications, and sequence polymorphisms of the gene encoding α-synuclein are also causally linked to Lewy body disease. In nonfamilial cases of Lewy body disease, the disease trigger remains unidentified but may range from industrial/agricultural toxicants and natural sources of poisons to microbial pathogens. Perhaps due to these peripheral exposures, Lewy inclusions appear at early disease stages in brain regions connected with cranial nerves I and X, which interface with inhaled and ingested environmental elements in the nasal or gastrointestinal cavities. Irrespective of its identity, a stealthy disease trigger most likely shifts soluble α-synuclein (directly or indirectly) into insoluble, cross-β-sheet aggregates. Indeed, β-sheet-rich self-replicating α-synuclein multimers reside in patient plasma, cerebrospinal fluid, and other tissues, and can be subjected to α-synuclein seed amplification assays. Thus, clinicians should be able to capitalize on α-synuclein seed amplification assays to stratify patients into potential responders versus non-responders in future clinical trials of α-synuclein targeted therapies. Here, we briefly review the current understanding of α-synuclein in Lewy body disease and speculate on pathophysiological processes underlying the potential transmission of α-synucleinopathy across the neuraxis.
Open Access
Hybrid_Gold
Repository Citation
Leak, R., Clark, R., Abbas, M., Xu, F., Brodsky, J., Chen, J., Hu, X., & Luk, K. (2024). Current insights and assumptions on α-synuclein in Lewy body disease. Acta Neuropathologica, 148 (1). https://doi.org/10.1007/s00401-024-02781-3